• A case of schizophrenia with congenital color vision deficiency: From the perspective of color universal design to promote medication adherence
• A Computer-Based Farnsworth-Munsell 100-Hue (CFM-100) Test in Pilots' Medical Assessments
• A demonstration of cone function plasticity after gene therapy in achromatopsia
• A new mutation in the <em>PDE6C</em> gene in achromatopsia
• Achromatopsia : Clinical aspects, diagnostics, genes, brain and quality of life
• Achromatopsia Showing Compound Heterozygous Mutations in <em>ATF6</em> by Whole Exome Sequencing: A Rare Case Report
• Achromatopsia-Visual Cortex Stability and Plasticity in the Absence of Functional Cones
• Achromatopsia: Genetics and Gene Therapy
• Achromatopsia: Long term visual performance and clinical characteristics
• Ametropia and Emmetropization in CNGB3 Achromatopsia
• An early onset cone dystrophy due to CEP290 mutation: a case report
• Analysis of Suspected Achromatopsia by Multimodal Diagnostic Testing
• Association Between Color Vision Deficiency and Myopia in Chinese Children Over a Five-Year Period
• Burden of ocular morbidities and color blindness among school-attending children in a foothill town of Uttarakhand State
• Central retina plays a decisive role in the suppression of pupillary escape
• Circumpapillary Retinal Nerve Fiber Layer OCT Imaging in a Parkinson's Disease Cohort-A Multidisciplinary Approach in a Clinical Research Hospital
• Clinical analysis of the Konan-Waggoner D15 color vision test using the Surface-Pro display
• Clinical and Genetic Features of Korean Patients with Achromatopsia
• Clinical and Molecular Characterization of Achromatopsia Patients: A Longitudinal Study
• Clinically relevant colour album test for the colour defective medical student
• Color Vision Testing, Standards, and Visual Performance of the U.S. Military
• Colour perception deficits after posterior stroke: Not so rare after all?
• Comparing Retinal Structure in Patients with Achromatopsia and Blue Cone Monochromacy Using OCT
• Comparison of Two Printed Pseudoisochromatic Tests for Color Vision Assessment
• Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia
• Cone contrast test-HD: sensitivity and specificity in red-green dichromacy and the impact of age
• Congenital Colour Vision Deficiency among Patients Attending Outpatient Department of Ophthalmology in a Tertiary Care Centre: A Descriptive Cross-sectional Study
• Deep Phenotyping of PDE6C-Associated Achromatopsia
• Detection of early bruises on apples using hyperspectral reflectance imaging coupled with optimal wavelengths selection and improved watershed segmentation algorithm
• Development of a Chromatic Pupillography Protocol for the First Gene Therapy Trial in Patients With CNGA3-Linked Achromatopsia
• Diagnosis and Treatment Options for Achromatopsia: A Review of the Literature
• Diagnosis of colour vision deficits using eye movements
• Dissociation between red and white stimulus perception: A perimetric quantification of protanopic color vision deficiencies
• Effect of laser eye protection devices on color perception
• ELECTRONEGATIVE ELECTRORETINOGRAM IN ACHROMATOPSIA
• Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration Population
• Elimination of the color discrimination impairment along the blue-yellow axis in patients with hypothyroidism after treatment with levothyroxine as assessed by the Farnsworth-Munsell 100 hue test
• Ethambutol optic neuropathy in the extended anti-tubercular therapy regime: A systematic review
• First-in-Human Gene Therapy Trial of AAV8-hCARp.hCNGB3 in Adults and Children With CNGB3-associated Achromatopsia
• Foveal hypoplasia in a patient with achromatopsia
• Frequency-dependent retinal responsiveness to sinusoidal electrical stimulation in achromatopsia
• Genetic and Clinical Characterization of Danish Achromatopsia Patients
• Genotypic and Phenotypic Spectrum of Foveal Hypoplasia: A Multicenter Study
• HIGH MYOPIA IS COMMON IN PATIENTS WITH X-LINKED RETINOPATHIES: Myopic Maculopathy Analysis
• High-Efficiency CRISPR/Cas9-Mediated Correction of a Homozygous Mutation in Achromatopsia-Patient-Derived iPSCs
• Identifiable universal fluorescent multiplex PCR equipped with capillary electrophoresis for genotyping of exons 1 to 5 in human red and green pigment genes
• Impact of color vision deficiency on the quality of life in a sample of Indian population: Application of the CVD-QoL tool
• IMPAIRMENTS OF L-CONE/M-CONE AND S-CONE-MEDIATED COLOR DISCRIMINATION IN MACULAR TELANGIECTASIA TYPE II
• In vivo imaging of a cone mosaic in a patient with achromatopsia associated with a GNAT2 variant
• Keratoconus, Dry Eye Syndrome, Overnight Orthokeratology, Achromatopsia and Uveitis in Children
• Lanthony D15 for Occupational Testing: Short-term Repeatability
• Limitation of standard pseudoisochromatic plates in identifying colour vision deficiencies when compared with genetic testing
• Longitudinal Evaluation of Changes in Retinal Architecture Using Optical Coherence Tomography in Achromatopsia
• Macular Pseudocoloboma in Achromatopsia
• MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model
• Mitochondria and Endoplasmic Reticulum Stress in Retinal Organoids from Patients with Vision Loss
• Modeling D15 test sequences in red-green anomalous trichromacy
• Molecular and Clinical Characterization of <em>CNGA3</em> and <em>CNGB3</em> Genes in Brazilian Patients Affected with Achromatopsia
• Morphological and Functional Aspects and Quality of Life in Patients with Achromatopsia
• Mouse Models of Achromatopsia in Addressing Temporal "Point of No Return" in Gene-Therapy
• Multiexon deletion alleles of ATF6 linked to achromatopsia
• Multimodal imaging including semiquantitative short-wavelength and near-infrared autofluorescence in achromatopsia
• Novel <em>OPN1LW/OPN1MW</em> Exon 3 Haplotype-Associated Splicing Defect in Patients with X-Linked Cone Dysfunction
• Novel Bi-allelic PDE6C Variant Leads to Congenital Achromatopsia
• Ocular Survey in Kathmandu University Medical Students
• Optical Gap Biomarker in Cone-Dominant Retinal Dystrophy
• Oscillatory Potentials in Achromatopsia as a Tool for Understanding Cone Retinal Functions
• Outer retinal transduction by AAV2-7m8 following intravitreal injection in a sheep model of CNGA3 achromatopsia
• Paternal Uniparental Isodisomy of Chromosome 2 in a Patient with <em>CNGA3</em>-Associated Autosomal Recessive Achromatopsia
• Poster Session II: Non-degenerating double cone opsin knockout mouse model of blue cone monochromacy
• Poster Session II: XR-based personalized active aid for color deficient observers
• Potential value of color vision aids for varying degrees of color vision deficiency
• Prenylation is essential for the enrichment of cone phosphodiesterase-6 (PDE6) in outer segments and efficient cone phototransduction
• Presumed topiramate-induced retinopathy in a 58-year-old woman
• Prevalence and awareness levels of color blindness among students of faculty of dentistry and dental prosthesis technology program
• Prevalence of Color Vision Anomalies among Dental Professionals
• Prevalence of Congenital Color Vision Deficiency in Southern Taiwan and Detection of Female Carriers by Visual Pigment Gene Analysis
• Quantitative and qualitative characterization of retinal dystrophies in canine models of inherited retinal diseases using spectral domain optical coherence tomography (SD-OCT)
• Reduced cone photoreceptor function and subtle systemic manifestations in two siblings with loss of SCLT1
• Refractive errors among commercial drivers
• Relatively mild blue cone monochromacy phenotype caused by various haplotypes in the L- and M-cone opsin genes
• REPEATABILITY AND LONGITUDINAL ASSESSMENT OF FOVEAL CONE STRUCTURE IN CNGB3-ASSOCIATED ACHROMATOPSIA
• Rod Monochromatism (Achromatopsia)
• Screening for mild anomalous trichromacy using the Ishihara plates test
• Seeing color following gene augmentation therapy in achromatopsia
• Silent progressive bilateral papillitis after COVID-19 vaccination: A case report
• Six Years and Counting: Restoration of Photopic Retinal Function and Visual Behavior Following Gene Augmentation Therapy in a Sheep Model of <em>CNGA3</em> Achromatopsia
• Spheno-Orbital Meningioma and Vision Impairment-Case Report and Review of the Literature
• Systematic analysis of CNGA3 splice variants identifies different mechanisms of aberrant splicing
• Tests for Potential Vision
• The Clinical Phenotype of CNGA3-Related Achromatopsia: Pretreatment Characterization in Preparation of a Gene Replacement Therapy Trial
• The impact of display saturation on visual search performance in congenital colour vision deficiency
• The VA-CAL Test Quantifies Improvement of Visual Acuity in Achromatopsia by Means of Short-Wave Cutoff Filter Glasses in Daily Living Conditions
• The Verriest Lecture: Pathways to color in the eye and brain
• Their loss is our gain: regressive evolution in vertebrates provides genomic models for uncovering human disease loci
• Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial
• Unique Haplotypes in OPN1LW as a Common Cause of High Myopia With or Without Protanopia: A Potential Window Into Myopic Mechanism
• UV/blue/green converted efficient red-NIR photoluminescence in Cr incorporated MgAl₂O₄nanocrystals: Site selective emission tailored through cation inversion and intrinsic defects
• Vision-Related Quality of Life in Primary Angle-Closure Glaucoma Patients with or without Visual Field Dysfunction
• Word and color impressions measured with normal and simulated deutan color stimulus sets in color vision normal and deuteranopic observers